Loading insider details...
Latest Form 4 (Jul 2, 2026): Grant/Award of 2,470 CGEM shares, $21.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 2,470 | $21.2K |
| Feb 25, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 3,601 | $52.1K |
| Feb 23, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 3,742 | $51.0K |
| Feb 19, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 230,000 | n/a |
| Dec 19, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 3,480 | $33.7K |
| Feb 27, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 3,756 | $32.0K |
| Feb 21, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 50,000 | n/a |
| Dec 20, 2024 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 3,482 | $39.7K |
| Feb 23, 2024 | Cullinan Oncology, Inc. (CGEM) | Grant/Award | 50,000 | n/a |
| Dec 22, 2023 | Cullinan Oncology, Inc. (CGEM) | Sale | 1,400 | $11.9K |